Brief: Generation Bio Reports Q1 Loss Per Share $0.46

Generation Bio

12/05/2021 22:26

May 12 (Reuters) - Generation Bio Co  GBIO.O :
    * GENERATION BIO PRESENTS PRECLINICAL DATA DEMONSTRATING
BROAD
POTENTIAL OF GENE THERAPY PLATFORM AT ASGCT AND REPORTS FIRST
QUARTER FINANCIAL RESULTS
    * Q1 LOSS PER SHARE $0.46
    * Q1 EARNINGS PER SHARE ESTIMATE $-0.45 -- REFINITIV IBES
DATA

Source text for Eikon:  ID:nGNX4Yqn58 
Further company coverage:  GBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))